Your browser doesn't support javascript.
Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.
Qu, Na; Hui, Zongguang; Shen, Zhixin; Kan, Chengxia; Hou, Ningning; Sun, Xiaodong; Han, Fang.
  • Qu N; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Hui Z; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Shen Z; Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Kan C; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Hou N; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Sun X; Department of Breast and Thyroid Surgery, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Han F; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Front Endocrinol (Lausanne) ; 13: 873027, 2022.
Article in English | MEDLINE | ID: covidwho-1862596
ABSTRACT
Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disease management; relevant changes include delayed diagnosis and treatment. The thyroid is an endocrine organ that is susceptible to autoimmune attack; thus, thyroid cancer after COVID-19 has gradually attracted attention. Whether COVID-19 affects the diagnosis and treatment of thyroid cancer has also attracted the attention of many researchers. This review examines the literature regarding the influence of COVID-19 on the pathogenesis, diagnosis, and treatment of thyroid cancer; it also focuses on drug therapies to promote research into strategies for improving therapy and management in thyroid cancer patients with COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thyroid Neoplasms / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Front Endocrinol (Lausanne) Year: 2022 Document Type: Article Affiliation country: Fendo.2022.873027

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thyroid Neoplasms / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Front Endocrinol (Lausanne) Year: 2022 Document Type: Article Affiliation country: Fendo.2022.873027